Grant Opportunities in Immunology and Microbiology
Bridging Research and Resources for Tomorrow's Discoveries
Innovations in Decentralized Pan-Orthoebolavirus Diagnostics
The Gates Foundation invites research institutes and companies to develop field-ready, decentralized pan-Orthoebolavirus diagnostics to combat Ebola outbreaks.
Published At
Advancing Adult Immunization Strategies: A Focus on the Impact of Respiratory Syncytial Virus (RSV) and Cardiorespiratory Outcomes
Pfizer Inc. offers grants up to $200,000 for medical education initiatives focused on the impact of RSV infection and cardiorespiratory outcomes in high-risk adults.
Published At
Call for Centre for Advanced Research (CAR)-2026, under Extramural Research Program
ICMR's CAR-2026 program provides research grants of INR 8-15 crores to experienced teams for decisive research solving critical public health problems in India.
Published At
OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic Malignancies
Pfizer offers quality improvement grants for healthcare institutions in Mainland China to optimize immunotherapy management for Multiple Myeloma and B-cell ALL patients.
Published At
MRFF 2026 National Critical Research Infrastructure
The Department of Health, Disability and Ageing offers $85M for the 2026 National Critical Research Infrastructure to support Australian medical research innovation.
Published At
Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
CDC's ERA program supports research and networks to eliminate or control non-malaria parasitic threats and neglected tropical diseases affecting Americans at home and abroad.
Published At
Call for Follow-on Research Grant under ICMR- Intramural Research Program-2026
ICMR offers Follow-on Research Grants to intramural researchers to bridge the gap between initial funding cycles and commercialization of promising research results.
Published At
Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
Pfizer Inc. offers research grants up to $100,000 for US-based investigators to evaluate the impact of early vs. delayed ritlecitinib treatment in Alopecia Areata patients.
Published At
Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia
CDC aims to reduce TB morbidity and mortality in India, Philippines, and Vietnam by strengthening case finding, prevention, treatment, and surveillance through innovative approaches.
Published At
Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya
The CDC - ERA supports research and public health evaluations in Kenya to prevent infectious disease threats, focusing on respiratory pathogens, vaccines, and AMR.
Published At